Omega Healthcare Investors, Inc.
NYSE:OHIREIT - Healthcare Facilities
-$0.86 today
- Market cap
- $14.33B
- Beta
- 0.58
- P/E (TTM)
- 21.0
- EPS (TTM)
- $2.13
- Dividend yield
- 6.00%
Volume 1.84M
Average 2.27M
OHI Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
Omega Healthcare Investors, Inc.NYSE: OHI
Depreciation & Amortization · Q2 FY2026 · quarter ended Jun 2026
Depreciation & amortization grows, but more slowly than its trailing trend
Q2 FY2026 depreciation & amortization of $81.84M rose 1.7% year over year, behind the +4.6% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 2.7% from the prior quarter. Over 3 fiscal years it compounded at -0.7% a year.
Context
- Depreciation & amortization amounted to 27.1% of revenue in FY2025, down 1.8 pp from a year earlier.
- Depreciation & amortization increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from +1.7% toward the trailing-twelve-month pace of +4.6%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 325.25M USD
- Year-over-year change
- +6.8%
- 4-year CAGR
- -1.2%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 325.25M | +6.8% |
| FY2024 | 2024-12-31 | 304.65M | -4.7% |
| FY2023 | 2023-12-31 | 319.68M | -3.8% |
| FY2022 | 2022-12-31 | 332.41M | -2.8% |
| FY2021 | 2021-12-31 | 342.01M | — |
Depreciation & Amortization vs competitors
How OHI compares with its peers on the latest reported figures
- OHI's LTM Jun 2026 depreciation & amortization of $330.85M is the 4th largest of the 11 companies compared; the peer median is $286.54M.
- Its year-over-year change of +4.6% is the 8th highest of 10, against a peer median of +25.8%.
- Depreciation & amortization amounts to 25.6% of revenue for OHI, versus a peer median of 22.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $2.68B | +33.1% | +17.0% | 19.6% | |
| LTM Jun 2026 | $1.47B | +23.5% | +8.2% | 22.8% | |
| LTM Sep 2026 | $1.09B | +1.8% | +12.9% | 48.6% | |
| LTM Jun 2026 | $330.85M | +4.6% | -0.7% | 25.6% | |
MPTMedical Properties Trust, Inc. | LTM Jun 2026 | $294.89M | -27.4% | -7.6% | 28.9% |
| LTM Sep 2026 | $294.27M | +35.0% | +3.9% | 11.0% | |
| FY2025 | $278.81M | — | — | 36.2% | |
| LTM Jun 2026 | $209.43M | +21.7% | -0.1% | 24.4% | |
| LTM Sep 2026 | $120.33M | +59.0% | +22.7% | 19.5% | |
| LTM Sep 2026 | $98.11M | +25.8% | +5.8% | 21.5% | |
| LTM Sep 2026 | $49.02M | +35.7% | +0.3% | 12.4% | |
| Peer median (excluding OHI) | $286.54M | +25.8% | +5.8% | 22.1% | |
Competitors are the stored peer set for OHI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 428.3M | 438.84M | 241.72M | 417.8M | 609.47M |
| Depreciation & Amortization | 342.01M | 332.41M | 319.68M | 304.65M | 325.25M |
| Deferred Income Tax | (10.69M) | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 21.42M | 27.3M | 0 | 36.7M | 44.19M |
| Change in Working Capital | (94.03M) | (45.58M) | (15.1M) | 32.85M | (2.95M) |
| Accounts Receivables | (75.38M) | (58.01M) | (3.66M) | (845K) | 2.89M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | (18.65M) | 12.43M | (11.44M) | 33.7M | (5.84M) |
| Other Non-Cash Items | 35.12M | (127.24M) | 80.24M | (42.57M) | (97.4M) |
| Operating Cash Flow | 722.14M | 625.73M | 626.54M | 749.43M | 878.55M |
| Capital Expenditures | (95.06M) | (47.22M) | (38.01M) | (37.76M) | 0 |
| Acquisitions (Net) | (16.21M) | (113K) | (202K) | (971K) | (122.09M) |
| Purchases of Investments | (164.79M) | (619.22M) | (739.92M) | 0 | 0 |
| Sales of Investments | 111.11M | 759.05M | 750.22M | 8.43M | 4.24M |
| Other Investing Activities | (359.21M) | 350.36M | 18.14M | (678.62M) | (421.94M) |
| Investing Cash Flow | (524.17M) | 442.85M | (9.78M) | (671.16M) | (539.79M) |
| Debt Repayment | 96.82M | 8.11M | (227.92M) | (487.48M) | (585.05M) |
| Common Stock Issued | 274.01M | 8.11M | 336.4M | 1.24B | 609.14M |
| Common Stock Repurchased | 0 | (142.27M) | 0 | 0 | 0 |
| Dividends Paid | (637.65M) | (632.89M) | (643.87M) | (685.45M) | (780.39M) |
| Other Financing Activities | (74.3M) | (22.4M) | 62.07M | (36.41M) | (81.96M) |
| Financing Cash Flow | (341.12M) | (789.45M) | (473.31M) | 26.32M | (838.26M) |
| Effect of Forex Changes | 7K | (2.9M) | 430K | (580K) | 5.33M |
| Net Change in Cash | (143.15M) | 276.23M | 144.09M | 104.01M | (494.17M) |
| Free Cash Flow | 627.07M | 578.51M | 588.53M | 712.69M | 878.55M |
Omega Healthcare Investors, Inc.
NYSE:OHI
Intrinsic Alpha fair value
Locked
Current Price
$47.09
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.